Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sylentis, S.A.
Age
18–45
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy volunteers, any gender
18 to 45 years of age,
Subjects must provide signed informed consent prior to participation in any study-related procedures
Body Mass Index between 19,5 and 29 kg/m2
IOP \</= 21 mmHg in both eyes
Have a BCVA (Best corrected visual acuity) of \>/= 0.8 (20/25) (Snellen scale), or \</= 0.1 (LogMar units)in both eyes
Normal Fluorescein Clearance Test in both eyes
Normal funduscopy in both eyes
You may not be if
Pregnant or breastfeeding females or those with a positive pregnancy test. Females of childbearing potential who will not use a medically acceptable contraceptive method from selection and during the hole study.
Current relevant disease, including respiratory disease, cardiovascular, endocrine, neurological, haematological, renal, neoplastic, hepatopathy, gastrointestinal distress, hypertension, or infectious acute processes
Previous chronic processes or with rebound characteristics that could interfere with study according to the investigator's judgment.
Volunteers who have received pharmacological treatment, including medicinal plants, during the four weeks previous to beginning the study.
Having used anti-cholinergics, betablockers and corticoids sporadically in the last 30 days whichever the route of administration, or any med by ocular or nasal administration route.
Case history of hypersensitivity to meds or any other allergic process
